Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
2,026,327
-
Share change
-
+152,086
-
Total reported value
-
$47,182,262
-
Price per share
-
$23.27
-
Number of holders
-
72
-
Value change
-
+$3,452,845
-
Number of buys
-
30
-
Number of sells
-
30
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q1 2023
As of 31 Mar 2023,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,026,327 shares.
The largest 10 holders included
Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, Wealthcare Advisory Partners LLC, MORGAN STANLEY, UBS Group AG, AMERIPRISE FINANCIAL INC, LPL Financial LLC, Royal Bank of Canada, JANE STREET GROUP, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.